Experimental blood pressure pill gets first safety check in humans
NCT ID NCT07174830
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study is testing an experimental drug called allisartan isoproxil in 54 healthy Chinese adults. Participants will receive a single dose of either the drug or a placebo to see how the body processes it and whether it causes any side effects. The goal is to gather safety and dosing information for future research.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Allisartan isoproxil (an experimental blood pressure medication)
- What this could lead to
- If successful, this study will provide key safety and dosing data to support future trials of allisartan isoproxil for high blood pressure.
- What could go wrong
- This is an early-phase study in healthy volunteers, not patients. It only tests single doses, so it cannot show whether the drug works for any condition. Side effects may still emerge.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shenzhen People's Hospital
RECRUITINGShenzhen, Guangdong, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common antifungal change how an experimental drug acts?
- Can a new injection help tackle obesity? a safety trial begins
- Will a new pill formula absorb the same? a trial puts it to the test
- Can a new drug tame Alzheimer's? early trial aims to find out
- Could sitting too much alter your nervous system?
- Could a cancer drug alter Metformin's effects? a trial investigates